Manchester Capital Management LLC Editas Medicine, Inc. Transaction History

Manchester Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$9.99 - $21.35 $19,980 - $42,700	2,000 Added 100.0%	4,000 $47,000
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $78,540 - $145,880	2,000 New	2,000 $82,000
Q2 2019 Aug 05, 2019	SELL	$20.48 - $27.76 $5,632 - $7,634	-275 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$19.43 - $26.41 $5,343 - $7,262	275 New	275 $7,000

250

57.1M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Manchester Capital Management LLC with notifications on news.